Healthcare AI Governance Market Size, Share & Growth [2034]
OVERVIEWFortune Business Insights forecasts substantial growth in the healthcare AI governance market through 2034, driven by regulatory requirements, institutional risk management, and enterprise demand for AI monitoring and validation platforms. This emerging market encompasses governance frameworks, AI auditing tools, performance monitoring systems, and compliance platforms. Market growth reflects recognition that healthcare organizations need dedicated governance infrastructure as AI deployment scales. Health systems are investing in AI governance councils, validation protocols, post-market surveillance systems, and integration with existing compliance and quality frameworks. Vendors are developing platforms to automate AI performance monitoring, bias detection, and regulatory reporting. The governance market remains nascent but accelerating. Key drivers include state-level AI healthcare legislation, FDA guidance on post-market monitoring, and institutional liability concerns. However, market development is constrained by lack of standardized governance metrics, competing regulatory frameworks across jurisdictions, and uncertainty about ultimate regulatory authority (FDA vs. states vs. health systems). ---
Subscribe to read full wiki analysis
Full wiki content — including source provenance, contradiction tracking, related pages, and analyst notes — is available to Subscriber members.
View Plans & SubscribeNew users get a 7-day trial — no credit card required.